Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial

International Journal of Stroke

Volumn 9, Issue 1, 2014, Pages 110-116

  Kidwell, Chelsea S ^a   Jahan, Reza ^b   Alger, Jeffry R ^b,c   Schaewe, Timothy J ^c   Guzy, Judy ^b,c   Starkman, Sidney ^b,c   Elashoff, Robert ^b   Gornbein, Jeffrey ^b   Nenov, Val ^b   Saver, Jeffrey L ^c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical trial; Embolectomy; Ischaemic stroke; MRI; Neuroimaging; Penumbra

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; EMBOLECTOMY SYSTEM; FEMALE; HUMAN; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTICENTER STUDY; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS THROMBECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SAMPLE SIZE; VERY ELDERLY; YOUNG ADULT;

CLINICAL TRIAL; EMBOLECTOMY; ISCHAEMIC STROKE; MRI; NEUROIMAGING; PENUMBRA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EMBOLECTOMY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; RESEARCH DESIGN; STROKE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84890815802     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00894.x     Document Type: Article

References (22)

1. Fisher M. Characterizing the target of acute stroke therapy. Stroke 1997; 28:866-872.
2. NINDS rt-PA Stroke Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1587.
3. Hacke W, Donnan G, Fieschi C etal. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363:768-774.
4. Lees KR, Bluhmki E, von Kummer R etal. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375:1695-1703.
5. Hacke W, Kaste M, Bluhmki E etal. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359:1317-1329.
6. Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 2004; 61:346-350.
7. Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 2011; 42:1952-1955.
8. Barber PA, Darby DG, Desmond PM etal. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998; 51:418-426.
9. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003; 34:2729-2735.
10. Albers GW, Thijs VN, Wechsler L etal. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60:508-517.
11. Davis SM, Donnan GA, Parsons MW etal. Effects of alteplase beyond 3h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7:299-309.
12. Kakuda W, Lansberg MG, Thijs VN etal. Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab 2008; 28:887-891.
13. Khatri P, Hill MD, Palesch YY etal. Methodology of the interventional management of stroke III trial. Int J Stroke 2008; 3:130-137.
14. Smith WS, Sung G, Saver J etal. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008; 39:1205-1212.
15. Smith WS, Sung G, Starkman S etal. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36:1432-1438.
16. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40:2761-2768.
17. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985; 312:932-936.
18. Tomsick T, Broderick J, Carrozella J etal. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 2008; 29:582-587.
19. Khatri P, Neff J, Broderick JP, Khoury JC, Carrozzella J, Tomsick T. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005; 36:2400-2403.
20. Adams HP Jr, Adams RJ, Brott T etal. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003; 34:1056-1083.
21. Adams HP Jr, del Zoppo G, Alberts MJ etal. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38:1655-1711.
22. Tilley BC, Marler J, Geller NL etal. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke 1996; 27:2136-2142.